Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
US parasite control company TyraTech has made progress in ramping up its product sales after it decided to focus solely on animal health.
A robust market for small animal innovations and vaccines has helped the German animal health industry report 3% growth in the latest financial year.
A new survey in the US shows that pet owners are largely ignorant of flea and tick infestations associated with companion animals.
Boehringer Ingelheim has become the leading player in terms of R&D expenditure in animal health.
Bayer Animal Health reported a 6% decline in revenues during the first quarter of the year, as sales growth was impacted by currency effects.
Following Boehringer Ingelheim's annual press conference, Animal Pharm editor Joseph Harvey spoke to the company's head of animal health about the ongoing integration of Merial and the division's R&D plans.
Boehringer Ingelheim Animal Health has confirmed its rise to become the industry's second-largest player with 2017 sales of €3.9 billion ($4.75 billion).
The European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) has paved the way for a label extension for Elanco's Credelio (lotilaner).
Alivira Animal Health has gained a considerable manufacturing footprint in Europe by purchasing a subsidiary from a fellow Indian veterinary medicines firm.
Although isolated geographically, Australia has an animal health sector hungry for new products. Animal Pharm analyst Malcolm Flanagan talks to Australian industry body head Ben Stapley about his country's prospects for innovation and veterinary product sales.
Zoetis has received several product approvals from the US FDA for combination feed additive treatments for chickens.
MSD Animal Health has gained authorization in Europe for an expanded indication of Panacur AquaSol (fenbendazole 200 mg/mL).
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.